158 related articles for article (PubMed ID: 34342986)
1. Quantitative NMR Study of Insulin-Degrading Enzyme Using Amyloid-β and HIV-1 p6 Elucidates Its Chaperone Activity.
Ramaraju B; Nelson SL; Zheng W; Ghirlando R; Deshmukh L
Biochemistry; 2021 Aug; 60(33):2519-2523. PubMed ID: 34342986
[TBL] [Abstract][Full Text] [Related]
2. Proteolytically inactive insulin-degrading enzyme inhibits amyloid formation yielding non-neurotoxic aβ peptide aggregates.
de Tullio MB; Castelletto V; Hamley IW; Martino Adami PV; Morelli L; Castaño EM
PLoS One; 2013; 8(4):e59113. PubMed ID: 23593132
[TBL] [Abstract][Full Text] [Related]
3. Degradation of Alzheimer's Amyloid-β by a Catalytically Inactive Insulin-Degrading Enzyme.
Sahoo BR; Panda PK; Liang W; Tang WJ; Ahuja R; Ramamoorthy A
J Mol Biol; 2021 Jun; 433(13):166993. PubMed ID: 33865867
[TBL] [Abstract][Full Text] [Related]
4. Proteolysis of mature HIV-1 p6 Gag protein by the insulin-degrading enzyme (IDE) regulates virus replication in an Env-dependent manner.
Hahn F; Schmalen A; Setz C; Friedrich M; Schlößer S; Kölle J; Spranger R; Rauch P; Fraedrich K; Reif T; Karius-Fischer J; Balasubramanyam A; Henklein P; Fossen T; Schubert U
PLoS One; 2017; 12(4):e0174254. PubMed ID: 28388673
[TBL] [Abstract][Full Text] [Related]
5. Toward Allosterically Increased Catalytic Activity of Insulin-Degrading Enzyme against Amyloid Peptides.
Kurochkin IV; Guarnera E; Wong JH; Eisenhaber F; Berezovsky IN
Biochemistry; 2017 Jan; 56(1):228-239. PubMed ID: 27982586
[TBL] [Abstract][Full Text] [Related]
6. Conformational states and recognition of amyloidogenic peptides of human insulin-degrading enzyme.
McCord LA; Liang WG; Dowdell E; Kalas V; Hoey RJ; Koide A; Koide S; Tang WJ
Proc Natl Acad Sci U S A; 2013 Aug; 110(34):13827-32. PubMed ID: 23922390
[TBL] [Abstract][Full Text] [Related]
7. The N-Terminus of the HIV-1 p6 Gag Protein Regulates Susceptibility to Degradation by IDE.
Schmalen A; Karius-Fischer J; Rauch P; Setz C; Korn K; Henklein P; Fossen T; Schubert U
Viruses; 2018 Dec; 10(12):. PubMed ID: 30545091
[TBL] [Abstract][Full Text] [Related]
8. The catalytic domain of insulin-degrading enzyme forms a denaturant-resistant complex with amyloid beta peptide: implications for Alzheimer disease pathogenesis.
Llovera RE; de Tullio M; Alonso LG; Leissring MA; Kaufman SB; Roher AE; de Prat Gay G; Morelli L; Castaño EM
J Biol Chem; 2008 Jun; 283(25):17039-48. PubMed ID: 18411275
[TBL] [Abstract][Full Text] [Related]
9. The irreversible binding of amyloid peptide substrates to insulin-degrading enzyme: a biological perspective.
de Tullio MB; Morelli L; Castaño EM
Prion; 2008; 2(2):51-6. PubMed ID: 19098445
[TBL] [Abstract][Full Text] [Related]
10. Molecular Determinants of Substrate Specificity in Human Insulin-Degrading Enzyme.
Stefanidis L; Fusco ND; Cooper SE; Smith-Carpenter JE; Alper BJ
Biochemistry; 2018 Aug; 57(32):4903-4914. PubMed ID: 30004674
[TBL] [Abstract][Full Text] [Related]
11. Characterization of insulin-degrading enzyme-mediated cleavage of Aβ in distinct aggregation states.
Hubin E; Cioffi F; Rozenski J; van Nuland NA; Broersen K
Biochim Biophys Acta; 2016 Jun; 1860(6):1281-90. PubMed ID: 26968463
[TBL] [Abstract][Full Text] [Related]
12. Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism.
Shen Y; Joachimiak A; Rosner MR; Tang WJ
Nature; 2006 Oct; 443(7113):870-4. PubMed ID: 17051221
[TBL] [Abstract][Full Text] [Related]
13. Insulin-degrading enzyme in brain microvessels: proteolysis of amyloid {beta} vasculotropic variants and reduced activity in cerebral amyloid angiopathy.
Morelli L; Llovera RE; Mathov I; Lue LF; Frangione B; Ghiso J; Castaño EM
J Biol Chem; 2004 Dec; 279(53):56004-13. PubMed ID: 15489232
[TBL] [Abstract][Full Text] [Related]
14. Structure of substrate-free human insulin-degrading enzyme (IDE) and biophysical analysis of ATP-induced conformational switch of IDE.
Im H; Manolopoulou M; Malito E; Shen Y; Zhao J; Neant-Fery M; Sun CY; Meredith SC; Sisodia SS; Leissring MA; Tang WJ
J Biol Chem; 2007 Aug; 282(35):25453-63. PubMed ID: 17613531
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis for the recognition and cleavages of IGF-II, TGF-alpha, and amylin by human insulin-degrading enzyme.
Guo Q; Manolopoulou M; Bian Y; Schilling AB; Tang WJ
J Mol Biol; 2010 Jan; 395(2):430-43. PubMed ID: 19896952
[TBL] [Abstract][Full Text] [Related]
16. Purified recombinant insulin-degrading enzyme degrades amyloid beta-protein but does not promote its oligomerization.
Chesneau V; Vekrellis K; Rosner MR; Selkoe DJ
Biochem J; 2000 Oct; 351 Pt 2(Pt 2):509-16. PubMed ID: 11023838
[TBL] [Abstract][Full Text] [Related]
17. Medium-Chain Length Fatty Acids Enhance Aβ Degradation by Affecting Insulin-Degrading Enzyme.
Mett J; Lauer AA; Janitschke D; Griebsch LV; Theiss EL; Grimm HS; Koivisto H; Tanila H; Hartmann T; Grimm MOW
Cells; 2021 Oct; 10(11):. PubMed ID: 34831163
[TBL] [Abstract][Full Text] [Related]
18. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.
Farris W; Mansourian S; Chang Y; Lindsley L; Eckman EA; Frosch MP; Eckman CB; Tanzi RE; Selkoe DJ; Guenette S
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4162-7. PubMed ID: 12634421
[TBL] [Abstract][Full Text] [Related]
19. Insights into Non-Proteolytic Inhibitory Mechanisms of Polymorphic Early-Stage Amyloid β Oligomers by Insulin Degrading Enzyme.
Abramov-Harpaz K; Miller Y
Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551314
[TBL] [Abstract][Full Text] [Related]
20. Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme.
Vekrellis K; Ye Z; Qiu WQ; Walsh D; Hartley D; Chesneau V; Rosner MR; Selkoe DJ
J Neurosci; 2000 Mar; 20(5):1657-65. PubMed ID: 10684867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
